Abstracts Archive - Page 1271 of 2425 - ACR Meeting Abstracts

Abstract Number: 982 • 2017 ACR/ARHP Annual Meeting
Epidemiology and Mortality in Systemic Sclerosis in South Korea: A Nationwide Population-Based Study
Kyong-Hee Jung¹, Seong-Ryul Kwon¹, Joo-Hyun Lee², Hyeong Sik Ahn³, Hyun Jung Kim³ and Gil Won Kang⁴, ¹Rheumatology, Inha University, Incheon, Korea, Republic of (South), ²Rheumatology, Inje University Ilsan Paik Hospital, Goyang, Korea, Republic of (South), ³Korea University, Seoul, Korea, Republic of (South), ⁴Chungbuk University, Cheongju, Korea, Republic of (South)
Background/Purpose: Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by small vessel vasculopathy, autoantibody production, and excessive collagen deposition in the skin and…
Abstract Number: 983 • 2017 ACR/ARHP Annual Meeting
Identifying Exposures to Chemicals in Patients with SLE – a Non-Targeted Exposome Approach Reveals Enrichment for Phthalates
Cristina Lanata¹, Thomas Lin², Maria Dall'Era¹, Jinoos Yazdany³, Patricia P. Katz¹, Laura Trupin³, Charles G. Helmick⁴, Roy Gerona⁵ and Lindsey A. Criswell¹, ¹Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ²Univeristy of California, San Francisco, SAN FRANCISCO, CA, ³Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, ⁴Centers for Disease Control and Prevention, Atlanta, GA, ⁵Obstetrics and Gynecology, University of California, San Francisco, SAN FRANCISCO, CA
Background/Purpose: Environmental exposures may play a substantial role in the pathogenesis of SLE. The goal of this study is to characterize the serum levels of…
Abstract Number: 984 • 2017 ACR/ARHP Annual Meeting
Identification of Key Screening Characteristics for Systemic Lupus Erythematosus Natural History
Kendra A. Young¹, Melissa E. Munroe², Joel M. Guthridge³, Diane L. Kamen⁴, Gary S. Gilkeson⁵, Michael Weisman⁶, David Karp⁷, John B. Harley⁸, Daniel J. Wallace⁶, Judith A. James⁹ and Jill M. Norris¹⁰, ¹Epidemiology, University of Colorado Denver, Aurora, CO, ²Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ³Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, OKC, OK, ⁴Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, ⁵Department of Medicine, Medical University of South Carolina, Charleston, SC, ⁶Cedars-Sinai Medical Center Division of Rheumatology, Los Angeles, CA, ⁷Rheumatology, UT Southwestern Med Ctr, Dallas, TX, ⁸Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁹Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ¹⁰Department of Epidemiology, Colorado School of Public Health, Aurora, CO
Background/Purpose: A prospective study of preclinical SLE disease evolution is needed to help elucidate critical aspects of disease etiology and early pathogenesis, and to identify…
Abstract Number: 985 • 2017 ACR/ARHP Annual Meeting
Heart Failure Hospitalizations Among SLE and Diabetes Mellitus Patients Compared to the General U.S. Medicaid Population
Sarah Chen¹, Medha Barbhaiya², Michael A. Fischer³, Hongshu Guan⁴, Candace H. Feldman⁵, Brendan M. Everett⁶ and Karen H. Costenbader⁷, ¹Brigham and Women's Hospital, Boston, MA, ²Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ³Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁴Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁵Rheumatology, Brigham & Women's Hospital, Boston, MA, ⁶Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁷Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Cardiovascular disease (CVD) risk is increased in SLE patients, compared to the general population and age- and sex-matched diabetes mellitus (DM) patients. Heart failure…
Abstract Number: 986 • 2017 ACR/ARHP Annual Meeting
Do Death Certificates Underestimate the Burden of Rare Diseases: The Example of Systemic Lupus Erythematosus Mortality in Sweden
Titilola Falasinnu¹, Marios Rossides², Yashaar Chaichian³ and Julia F Simard⁴, ¹Health Research and Policy, Stanford University, Stanford, CA, ²Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden, ³Medicine, Immunology & Rheumatology Division, Stanford School of Medicine, Stanford, CA, ⁴Division of Epidemiology, Health Research and Policy Department, Stanford School of Medicine, Stanford, CA
Background/Purpose: Routine data sources such as death certificates are used to estimate the burden or cost of disease in a population. However, mortality due to…
Abstract Number: 987 • 2017 ACR/ARHP Annual Meeting
Death Certificates Do Not Accurately Identify SLE Patients
Kelly Kaysen, Cristina Drenkard, Gaobin Bao and S. Sam Lim, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA
Background/Purpose: Mortality rates are higher in SLE patients compared to the general population, and research on SLE mortality is ongoing. The majority of mortality studies…
Abstract Number: 988 • 2017 ACR/ARHP Annual Meeting
Association of Ultraviolet-B Radiation and Risk of SLE Among Women in the Nurses’ Health Studies
Medha Barbhaiya¹, Jaime Hart^2,3, Susan Malspeis⁴, Sara K. Tedeschi⁵, David J. Kreps⁵, Trang VoPham⁶, Jeffrey A. Sparks⁷, Elizabeth Karlson⁵, Francine Laden^2,3,8 and Karen H. Costenbader⁵, ¹Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ²Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, ³Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁴Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁵Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁶Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, ⁷Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁸Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
Background/Purpose: Ultraviolet-B radiation (UV-B) exposure may lead to worsened photosensitivity, rashes, and systemic flares among SLE patients. Although UV-B radiation damages keratinocytes and may result…
Abstract Number: 989 • 2017 ACR/ARHP Annual Meeting
Impact of DMARD Treatment on Risk of Repeat Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis
Jeffrey A. Sparks¹, Tamara Lesperance², Neil A. Accortt³ and Daniel H. Solomon⁴, ¹Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ²DOCS Global, Inc., North Wales, PA, ³Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, ⁴Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Chronic inflammatory diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and psoriasis (PsO) increase the risk of cardiovascular (CV) disease. However, it is…
Abstract Number: 990 • 2017 ACR/ARHP Annual Meeting
Higher Omega-6 to Omega-3 Fatty Acid Ratio Is Associated with Increased Odds of Inflammatory Arthritis in a Health Fair Population Positive for Anti-Citrullinated Protein Antibodies (ACPA)
Kristen J. Polinski¹, Ryan W. Gan², Elizabeth A. Bemis¹, M. Kristen Demoruelle³, Michael J. Clare-Salzler⁴, V. Michael Holers⁵, Kevin D. Deane⁶ and Jill M. Norris⁷, ¹Epidemiology, Colorado School of Public Health, Aurora, CO, ²Colorado School of Public Health, University of Colorado Denver, Aurora, CO, ³1775 Aurora Ct, 1775 Aurora Ct, Aurora, CO, ⁴Experimental Pathology, University of Florida, College of Medicine, Gainesville, FL, ⁵Rheumatology Division, University of Colorado School of Medicine, Aurora, CO, ⁶Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, ⁷Department of Epidemiology, Colorado School of Public Health, Aurora, CO
Background/Purpose: We previously found that lower levels of omega-3 fatty acids (n-3 FA) were associated with the presence of inflammatory arthritis (IA) as well as…
Abstract Number: 991 • 2017 ACR/ARHP Annual Meeting
Publication Timeliness of the Randomized Controlled Trials of Drug Therapy for Inflammatory Arthritis
Vyjayanthi Ganga¹, Mohan Edupuganti² and Nasim A. Khan³, ¹St. Vincent Healthcare System, Little Rock, AR, ²Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, ³Rheumatology, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR
Background/Purpose: Timely publication of randomized controlled trials (RCTs) is crucial for their potential impact on patient care. We assessed the publication timeliness of drug therapy…
Abstract Number: 992 • 2017 ACR/ARHP Annual Meeting
The Effect of Anti-TNF Therapy on Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis over One Year – Real Life Data from the Czech Biologics Registry Attra
Jakub Zavada¹, Lenka Szczukova², Karel Pavelka³ and Jiri Vencovsky³, ¹Institute of Rheumatology, Prague, Czech Republic, ²Institute of Biostatistics and Analyses. Faculty of Medicine, Masaryk University, Brno, Czech Republic, ³Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
Background/Purpose: The ATTRA registry captures more than 95% of patients with RA, PSA or AS treated with biologics in the Czech Republic (CZ). In CZ,…
Abstract Number: 993 • 2017 ACR/ARHP Annual Meeting
Increase in Prevalence of Psoriasis Arthritis over Time: Analysis of Claims Data from 65 Million People in Germany from 2009 to 2012
Philipp Sewerin¹, Matthias Schneider², Benedikt Ostendorf¹ and Ralph Brinks³, ¹Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Düsseldorf, Germany, ²Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, ³Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Duesseldorf, Germany
Background/Purpose: Epidemiological studies are important contributors for our understanding of psoriatic arthritis (PsA). Currently, there are no data about temporal trends of prevalence of PsA…
Abstract Number: 994 • 2017 ACR/ARHP Annual Meeting
Increasing Population Burden of Psoriatic Disease in Ontario, Canada – a Longitudinal Cohort Study
Lihi Eder^1,2, Jessica Widdifield³, Cheryl F. Rosen⁴, Dafna D Gladman^2,5, Raed Alhusayen⁶, Michael Paterson⁷, Stephanie Cheng⁷, Shirin Jabbari⁷, Willemina Campbell⁸, Sasha Bernatsky⁹ and Karen Tu⁷, ¹Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada, ²Medicine, University of Toronto, Toronto, ON, Canada, ³University Health Network, Toronto, ON, Canada, ⁴Dermatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁵Rheumatology, University Health Network, Toronto, ON, Canada, ⁶Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ⁷Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁸Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, ⁹Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: There is limited information on the epidemiology of psoriasis and psoriatic arthritis (PsA) in North America. The aims of this study were to estimate…
Abstract Number: 995 • 2017 ACR/ARHP Annual Meeting
The Epidemiology of Psoriatic Arthritis in Israel – a Population-Based Study
Lihi Eder^1,2, Arnon Dov Cohen³, Ilan Feldhamer⁴, Sari Greenberg-Dotan⁴, Eraz Batat⁴ and Devy Zisman⁵, ¹Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada, ²Medicine, University of Toronto, Toronto, ON, Canada, ³3Chief Physician’s Office, Central Headquarters, Clalit Health Services, Tel Aviv, Israel, ⁴Chief Physician’s Office, Central Headquarters, Clalit Health Services, Tel Aviv, Israel, ⁵The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
Background/Purpose: There is limited information on the epidemiology of Psoriatic Arthritis (PsA) in general and in Middle Eastern populations in particular. The aims of this…
Abstract Number: 996 • 2017 ACR/ARHP Annual Meeting
Accuracy of Canadian Administrative Health Data in Identifying Patients with Psoriasis and Psoriatic Arthritis Using Primary Care Medical Records As the Reference Standard
Lihi Eder^1,2, Jessica Widdifield³, Cheryl F. Rosen⁴, Dafna D Gladman², Raed Alhusayen⁵, Michael Paterson⁶, Stephanie Cheng⁶, Shirin Jabbari⁶, Willemina Campbell⁷, Sasha Bernatsky⁸ and Karen Tu⁶, ¹Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada, ²Medicine, University of Toronto, Toronto, ON, Canada, ³University Health Network, Toronto, ON, Canada, ⁴Dermatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁵Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ⁶Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁷Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, ⁸Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: We assessed the accuracy of algorithms to identify patients with psoriasis and psoriatic arthritis (PsA) in administrative health data in a validation set derived…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].